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DesOloglein 3 is the autoinunune target of pemphi-
gus vnlgaris. Most, if not all, pathogenic autoanti-
bodies are raised against conformational epitopes on 
deslDoglein 3. In this study, we examined whether 
posttranslational modification in endoplasmic retic-
uhun is required for the proper three-dimensional 
structure formation of recolnbinant pemphigns vul-
garis antigen. Previously, we have produced by bac-
ulovirus expression a secreted forln of desmoglein 3, 
PVIg, which represents equivalent conformational 
epitopes of the native antigen and showed that PVlg 
is able to immunoadsorb heterogeneous autoanti-
bodies from pemphigus vulgaris patients' sera. To 
elucidate the role of proteolytic processing, we con-
structed a mutant PVlg molecule, PVlg-fXa, whose 
putative endoproteolytic cleavage site was replaced 
by the recognition sequence of serum coagulation 
factor Xa. PVlg-fXa was produced without proteo-
lytic processing; however, exogenous treatlnent of 
P atients with pemphigus have circulating autoantibodies against a desJ11osomal transmembrane component, des-moglein (Stanley, 1993; Amagai, 1995, 1996). Patho-genic autoantibodies in pemphigus vu lgaris (PV) and pemphigus foljaceus target desmoglein 3 (Dsg3) and 
desmoglein 1 (Dsg1), respective ly. Previously, with the baculovirus 
expression system we produced secreted form s of recombinant 
Dsg3 and Dsg1, which were termed PVlg and PFlg, respectively. 
T h ese recombinant prote ins were ab le to immunoadsorb heteroge-
neous autoantibodies from PV or pemphjgus foliaceus sera and 
completely blocked indirect immunofluorescence staining on nor-
mal human skin, and eliminated pathogenic activities of patients ' 
sera (Amagai e/ ai, 1994, 1995a). Once these baculoproteins were 
denatured, however, they no longer showed il1"lmunoadsorptive 
activities (Amagai e/ ai, 1995b) . Therefore, we concluded that the 
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PVlg-fXa with factor Xa resulted in cleavage of the 
prosequence. Interestingly, not only the processed 
PVlg-fXa, but also the unprocessed form, showed the 
immunoadsorptive activity. Furthernlore, to eluci-
date the role of endoplasmic reticnlum signal peptide 
at the amino terminus, we constructed another nlU-
tant, PVlg-..:lsig, which lacks the signal peptide and 
prosequence. PVIg-..:lsig was not secreted and accu-
mnlated in the cytosol. PVlg-..:lsig failed to show the 
immunoadsorption. Together with our previous find-
ing on the role of glycosylation, these observations 
indicate that the conformational epitopes of the re-
combinant pemphigus antigen are not affected either 
by glycosylation or proteolytic processing, although 
they need to be formed in the endoplasmic reticu-
lum, and emphasize the importance of conformation 
of the antigen in pathogenic autoantibody binding. 
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PVTg and PFIg baculoproteins represcnt equivalcn t epitopes of the 
respective nati ve antigen and that these pathogenic autoantibodies 
recognize confon11ational epitopcs rather than sequential epitopes. 
These conformational epitopes of pcmphigus antigen were gen-
eratcd by eukaryotic cells, such as in sect cells o r COS7 cell s, but 
not by bactet;a (Amagai e/ ai, 1992) . Unlike bactcria , cu caryo tic 
ce lls perform a series ofposttranslational modifications to add more 
specific featmes or function to naked peptides . As in m ost trans-
membran e or secretory proteins, Dsg3 has a signal peptide at the 
amino terminus (Amagai ct ai, 1991) that directs the prote ins from 
the cytosol to endoplasmic reticulum (ER). Dsg3 is known to be 
glycosylated (Stan Icy e/ Il l , 1982) and considered to be synthesized 
as an inactive pt'ecmsor protein with a prosequcnce that undergoes 
cleavage and rcmoval during processing of th e molecul c, as fou nd 
in E-cadherin (Ozawa and Kemlcr, 1990) . 
The aim of this study was to dctc rmine whether posttranslational 
modifi ca tion is required for the Dsg3 recombinant protein to be 
folded properly and express the conformational epitopes of the 
native Dsg3. Especially, we focused on the role of proteolytic 
processing of the proscquen ce and the amino-terminal signal 
peptide. W e constru cted mutant PVlg molecu les, whose proteo-
lytic processing or transport into the ER is inhibited, and deter-
mined their immunoadsorptive activitics. T he results indicate that 
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EXTRACElLULAR DOMAINS Of Osg3 CONSTANT REGION OF 
SPEC I EC2 EC3 EC4 EC5 HUMAN IgG I 
1111111111 ,,111111 ,1111111 ,111 ,. ,11111,1111111111111 
--endogeous protease - _ , 
PVlg ···RRQKR EWVKFAK··· 
FaClor Xa 
+ PVlg . IXa ... R~ E W V K FA K ... 
PVlg·65lg ~EWVKFAK··· 
F igure 1. Molecular structure of the PVlg baculoprotein and 
amino acid sequences of the wild type and mutants at the proteo-
lytic cleavage site. T he rccognition sequence by cndogenous proteolytic 
cnzymes of Dsg3 is R-R-Q-K-R. which is hjghly conserved among 
cadherins. T his conserved sequcnce was substituted with that of blood 
coagulation f.,ctor Xa (I-E-G-R .• IIl1derl illed) in PVlg- fXa . T he signa l pcptide 
and prosequcncc was elim inated in PVlg-Llsig. The substituted amino acids 
arc cire/ed. 
transport to ER by sig n al peptide, but n ot proteolytic processing, is 
required for formation of the conform ational epitopes of the 
recombinant p emphigus antigen. 
MATERJALS AND METHODS 
Human Sera PV sera used in this study werc obtaincd from patients w ith 
clinica ll y and hjstologically typica l PV. 
cDNA Construction Plasmid pEVmod-PV lg with the entirc extracellu-
lar doma in of Dsg3 fused with the constant region of human IgG1 has bcen 
described previously (Amagai et ai, 1994). T he putative endoproteolytic 
cleavage site of Dsg3 (RRQKR) was substituted with the recognition 
sequence of blood coagulation f.,cto r Xa (IEGR) by using scqucntial 
polymerase chain reaction (PCR) (Fig 1). In brief. thc first step PCR was 
ca rried out on pEVmod-PVl g to generatc two fragmen ts (primcrs A and B 
for fragment 1 , primers C and D for fragment 2) 'with mutations for factor 
Xa recognition site at the 3' end and 5 ' cnd, respectively. T he two 
fragl11 cnts encol11passing the 111utation were annea.led with each other and 
extended by mutually primcd synthesis. Subsequently , thi s fragmcnt was 
reamplified by a second PCR step using primers A and D. T he fo llowing arc 
the primers used in this sequential PCR: 5'-primer A, 5'-GAA-GAT-CTC-
CT A-T AA-A T A-TGG-GGC-TCT -TCC-CCA-G-3'; 3' -primer B. 5'-
CCA-TTC-ACG-GCC-TTC-GAT-TCT-TTT-AGC_TTG_TTG_C_3" 5'-
primcr C, 5' - GAA-TCG-AAG-GCC-GTG-AAT -GGG-TGA-AAT-ITG-
C-3'; 3'-primer D, 5'-TTT-TAG-AAT-TCA-AGT_GG_3'. The fina l PCR 
product containing thc factor Xa recognition sitc was digested witl1 Bgill 
and EwlU and ligatcd together with BglIl-EcoRJ-cut pEVmod-PVlg. This 
construct was des ignated pEVmod-PVlg-fXa. 
Another mutant, pEVmod-PVlg-Llsig, which lacks the signal peptide and 
prosequence of Dsg3, was constructed . 5' PCR primcr E was designed to 
have thc Kozak consensus sequence (Kozak. 1987) at the translation 
initiation site and an extra methjonine residue immediately upstream of the 
<Imino terminu s of the mature form of PVlg (Fig 1). T he mutated cDNA 
was amp li fied 011 pcDNA1-PVIg (Amagai e/ nl. 1994) using primers E and 
D; 5'-primer E, 5'-TAA-GGA-ATT-CAG-ATC-TCG-CCA-TGG- AAT-
GGG-TGA-AAT-TTG-CCA-AAC-3'. T he PCR product was digested 
with Bg/ll alld EcoRI and ligated with BglIJ-EwIU-cut pEVmod-PVlg. 
Production of Mutated Baculoprotcins for Dsg3 pEVmod-
PV Ig-fXa and pEVmod-PVlg-Llsig we rc cotransfected with the 13aculogold 
baculovirus DNA (Pharmingell. San Diego, CAl into cultured insect Sf9 
cells, and recombinant viruses were obtained, as previously reported 
(Amagai et nl, 1994, 1995a). For baculoprotein production. High Five cell s 
(Invitrogen. San D iego, C Al cu ltu red in serum-free EX Cell 405 medium 
U RH Biosciences. Lenexa. KS) were infected with high-titer virus stock 
and incubated at 27°C for 3 d . PVIg-fXa was secreted in culture superna-
tant. PVlg-Llsig was produced in the cytosol and extracted w ith an 
extractio n buffer [1 'XI Nonidet P-40, 1 mM phenylmethanesul fony l fluoride, 
20 /-Lg aproti nin per mi . 0.5 111M calcium chloride in PBS( - »). Whcn 
necessary, these baculoproteins were concentrated 10- to 20-fo ld with 
Centriprep 30 (Amicon, Beverly, MA) or purifIed on protein A-Scpharose 
(Pharmacia, Uppsa la, Sweden) . 
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Figure 2. Irnrnunoblo t analysis of normal and mutant PVIg bacu_ 
loproteins. Uaculopl'oteins in culture supernatants (PVlg and PVlg-fXa) Or 
cell extracts (PVl g-Llsig) wc re purified on protein A-Scpharose and visu_ 
ali zcd by immunoblotting using alka line phosphatase-conjugated anti-
human IgG antibodies. PVIg-fXa was treated with factor Xa on protein 
A-Sepharose. Lalle J, PVIg; Inl/e 2, PVIg-fXa; Inl/e J , PVIg-fXa with 
trcatment by facto r Xa; Inll e 4, PVIg-Llsig. ~, -, and [> indicate tbe 
precursor form of PVlg, mature form of PVIg. and nonglycosylated 
processed form of PVI g. respectively. 
Immunoblot Analysis Purified baculo prote ins with protein A- Sepba_ 
rose were size-fractionated by sodium dodecyl su lfate-po lyacrylamide gel 
elcctrophoresis. transferred to a polyvinylidine difluoride membrane (Mil-
lipore , Bedford, MA), and dctected by alkalinc phosphatase- conjugated 
anti-human IgG antibodies (Zymed Laboratories . San Francisco. CAl. 
Immunoadsorption Assay PV sera were seriall y diluted at 1 :20, 1 :40, 
and 1 :80 with the concentrated so lu tion con ta ining PVIg, PVlg-fXa, Or 
PVIg-Llsig recombinant protein or w ith the same dilutions of a 1:1 mL"CUr e 
of the above solu tion and culture supernatant containing PFlg recombinant 
protein (Amagai c/ nl, 1995a). Aftc r incubation at 4°C overnight, the diluted 
sera were used for inllTIUl1ofiuorcsccncc. In S0l11C cxperinlcnts, PV sera \vere 
incubated with the baculoprotein bound on protein A-Sepharose at 4°C 
overnight and then serially diluted with Tris(hydroxymethyl)-amillometh_ 
'Ill e-buffered sa line [10 mM Tris(hydroxymethyl)-aminomethane, pH 7.4, 
150 mM NaCI) conta in ing 1 mM calcium chloride (TBS-Ca) and used for 
immunofluorescence. as previously described (Amagaj et nl. 1995a , 1996). 
The prosequcnce of PVIg-fXa baculoprotein, which was purified on 
protein A-Sepharose, was cleaved by incubation with serum coagulation 
factor Xa (1 mg per ml, N ew England 13ioLabs, 13everly, MA) in TBS- Ca at 
4°C overnight. Typica lly, PVlg-fXa in 2 ml of cul ture supernatant \Va 
purified on protein A-Sepharose and then incubated with 2 1'1 of facwr X a 
(1 mg per ml). 
Imntunofluorescence Immunoreactivity of PV autoantibodies was de-
tectcd by indirect immunofluorescence using a 1 :50 dilution of flu orescein 
isothiocyanate- conjugated anti-human IgG antibod ies (Dako. Copenhagen. 
Denmark). 
RESULTS AND DISCUSSION 
Production of Mutant PVIg Baculoprotein with the Precur-
sor Segment T h e putative e ndoproteolyt ic cleavage site ofDsg3 
(Arg-Arg-Gln-Lys-Arg) is hig hly con served amon g cadhcnns 
(Amagai el ai, 1991). To express mutant PVlg polypeptide, PVlg-
£Xa, conta ining the precursor segment, we replaced this sequence 
with the recognition site (Ile-Glu-Gly-Arg) of serum coaggulation 
factor Xa, which is not expected to b e u sed by endogenou 
proteases (Fig 1). Recombinant bacu loviru s conta ining th e mutanr 
PVlg cDNA was infected into High Five cultured insect celi s, and 
PVlg-£Xa was produced in c ulture supernatant without cleavage of 
the prosequence. PVlg-£Xa was produced as a sing le 110-kDa band 
(Fig 2, lall e 2), whereas PVlg was produced as major 107-kDa and 
minor 11 O-kDa bands, w hich are considered to be processed and 
unprocessed forms (Amagai eJ aI, 1994) (Fig 2, lall e 1) . The 
treatment of PVlg-£Xa recombinant protein with f.,cto r Xa gen er-
ated the 107 kDa band (Fig 2, lalle 3), which was indistinguishable 
by its e lectroph oretic mobiLity fro m the 107-kDa m ature PVlg. 
Inc ubation of PVlg-£Xa with PV sera or normal sera did not 
generate the 107-kDa band (data not shown) , excluding a possibil-
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icy that i.I11111unoadsorpti ve aCtlV lty by PVIg-tXa is du e to the 
processed form of PVlg-fXa during incubation with hum an sera. 
These fi ndin gs indicate that the replacem en t of the recogni tio n 
sequence efricientl y inhibi ted the proteol yti c processing and that 
the Hlu tant baculo protein ca n be converted in to the m ature form by 
exogenous trea tment w ith f.,ctor Xa. 
PVIg without Cleavage of the Prosequence Retains Enough 
Con£ormatioll to Relllove Inllllunoreactivity of PV Sera 
To determ ine w hethe r the mutant PV lg-fXa baculoprotein con-
tains conformational epitopes of Dsg3, w e pe rform ed an immuno-
adsorp tion assay (Al11agai ef a/ , 1994, 1995a, 1995b). PV patients' 
autoa ntibodies are raised aga in st va rio us conform ational cpitopes. 
T h e refore, immuno adsorpti on of the hete rogeneous autoantibodies 
indica t es that the adsorben t represcnts eq ui va len t confo rm atio nal 
epitopes of the na tive antigen. In this stu dy, we used a tota l of 18 
PV sera; three PV sera contain onl y anti-Dsg3 IgG, w hich sta in ed 
keratinocyte cell surfa ces in the lower epide rl11is by immuno flu o-
resce nce, and the rCl11 a in dcr of 15 PV scra contain <lnti-Dsg1 IgG in 
addition to anti -Dsg3 IgG, which staincd thro ughout the epide rmis 
(Eyre a nd Sta nl ey, '1 98tl; Am agai cl a/, 1996). Thc immun o reactivi ty 
of the fi rst three PV scra was rem oved by incubati o n w ith intact 
PVIg baculoprote in (Fig 3A,B). Interestin g ly, the mutant PVlg-
fXa wi thout c leavage of the prosequ cnce was also able to immu-
noadsorb autoantibod ies against Dsg3 from the PV sera as efri-
Dendy as the intact PVl g (Fig 3C). 
To determin e the imrl1un oadsorpti ve activity ofthcse baculopro-
teins in the rema ind er of 15 PV sera, an ti-Dsg1 IgG was rem oved 
by in c ubation w ith the PFlg baculoprotein , w hich is known to 
express confo rm atio na l epitopes of Dsg l (Amagai el a/, 1995a). 
After a dsorption w ith PFl g, all of thesc PV scra stained o nl y the 
lower e pidermis, w here Dsg3 is exp ressed (F ig 3E) (Amagai Ci a/, 
1996) . T he immun o reacrivity of anti-Dsg3 IgG in these 15 PV sera 
was e lim ina ted by in cubatio n not o nl y w ith the intact PVl g, but 
also with the unprocessed PVlg-fXa (Fig 3F,G) . Pro cessed PVlg-
DCa b y treatm ent w ith facto r Xa co uld also remove immuno reac-
tivicy of all of the 18 PV sera tested (data not shown). T hese 
obser v ations together indica te tha t the mutant PVl g-fXa w itho ut 
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Figure 3. Immunoadsorption assay with nor-
mal and mutant PVIg baculoproteins. A PV 
serum containing only anti-Dsg3 IgG (A-D) was 
incubated with solu tion containing no PVlg (A), 
PV lg (B), PVlg-tXa (e), or PVlg-C.sig (D) and ll sed 
for inlllluno Ru o rescencc stainjng of nornla l hlllnan 
skin . Another PV serum containing both anti-Dsg3 
and anti-Dsgl IgG (E-H ) was incubated with a 1:1 
solution mixture ofPFlg and no PVl g (E) . PVlg (F) , 
PVlg-tXa (G). or PVlg-C.sig (H). Thc figlll'cs arc 
shown at 1 :20 dilution of the patient's scra. Senle hnr, 
50 f.L1l1 . 
cleavage of the prosequ en ce retain enough conformation to immu-
noadsorb he terogeneous anti-Dsg3 autoantibodies in PV sera. 
T his no tion led us to hypothesize that the precursor prote in of 
Dsg3 before proteolytic processing might have the conformation of 
the m ature fo rm . In gerneral , however, proteolytic processing is 
co nsidered to re lease a conform ational restraint on an in active 
precursor to gen e ra te a biologica lly active protein (Neurath , 1989). 
In fact , correct proteol yti c cleavage of the prosequence is required 
fo r uvomorulin (E-cadherin) to mcdiate homophilic interaction , 
because cells expressing the unprocessed mutan t peptide showed 
no E- cadherin-mediated adh esio n (Ozawa and Kemler, 1990). 
T herefore , it has been sugges ted that proteolytic processing creates 
the active form of mature classic cadherins by conformational 
changes lead ing to the exposure of active binding sites. T herefore, 
o ur observatio n suggests that proteolytic processing may be impor-
tant fOl' additiona l conforma tiona l changes, or unmasking of func-
tional epi topes, th at are n ot detected in o ur immunoadsorption 
assay. 
Removal of Signal Peptide Abolished the Immunoadsorp-
tive Activity of the PVlg Baculoprotein Synthesis of secre-
tory prote ins o r transmembrane proteins begins in the cytoplasm , 
but they are then targe ted to the ER membrane by signal peptides, 
which are characterized by a continuous str e tch of apolar amino 
acids often located at the amino terminus of precursor molecul es 
(von Heijne, 1990; R apoport, 1992). Peptides without til e ER 
signal peptide are synthesized in free ribosomcs in the cytoso l. Dsg3 
has a signal peptide at th e amin o terminus of the precursor molecule 
(Amagai ef a/, 1991). We asked whether the signal peptide is 
necessary for th e PVlg baculoprote in to generate the confo rma-
tional epitopes. To address this question, we constructed another 
ll1utant PVlg, PVl g- ilsig, whi ch lacks the signal peptide and 
proscquence (Fig 1). PVl g-t.sig was not sec reted and produced in 
the cytosol of Hi gh Five cell s afte r infection with the recombinant 
baculovirlls. T herefore, PVl g-ilsig was extra cted with an extrac-
tion buffe r conta inin g 1 % N onide t P-40, which does not affect the 
conformatio n of the baculoproteins (Amagai e/ a/, 1995b). PVTg-
t.s ig was de tec ted as a sing le band of97 kDa (Fig 2 , /all e 4), which 
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comigrated with nonglycosylated mature form of PVIg in the 
presence of tunicamycin (data not shown). T hese observations 
indicated that PVIg-L!.sig was not in the secretory pathway and was 
not transported into the ER. T he immunoadsorption assay with 
PVIg-L!.sig as an adsorbent showed that this mutant failed to remove 
immunoreactivi ty of PV sera tested (Fig 3D,H), indicating that 
PVIg-L!.sig did not accurately reflect the conformation of the native 
Dsg3. Improper folding of PVIg-L!.sig produced in the cytosol was 
not due to the absence of calcium, because the dialysis ofPVIg-L!.sig 
against 1 mM calcium did not restore the immunoadsorptive 
activity (data not shown). 
In the previous study, we demonstrated that the conformational 
epitopes on the PVlg and PFIg baculoproteins are calcium depen-
dent, because chelating calcium from the solution contain ing the 
baculoproteins by ethylenediamine tetraacetic acid abolished im-
munoadsorption, but immunoadsorption was restored after dialysis 
against 1 mM calcium (Amagai el ai, 1995b). Furthermore, we also 
showed that the conformational epitopes are not dependent upon 
the presence of carbohydrate moieties, because nonglycosylated 
forms of baculoproteins produced in the presence of tunicamycin 
retained their immunoadsorptive activ ity (Amagai et ai, 1995b). In 
this study it was shown that proteolytic processing of the precursor 
sequence is not necessary either. Glycosyla tion and proteolytic 
processing are two of the major posttranslational modifications that 
occur in the ER. T he transport into the ER itself was required, 
however, and the conformational epitopes of baculoproteins 
needed to be formed in the ER. T hese observations emphasize that 
conformation of antigenic determinants is important in the binding 
of pathogenic autoantibodies to the antigen and that recombinant 
antigen of this size (- 100 kDa) sho uld be produced by eukaryotic 
expression system. 
This work lIIas sllpporled by a Gralll-Ill-Aid Jar Seiell!ific Research ji-Olll Ih e Millis!ry 
oj Edllwtioll, Seiellee, olld Cll ltllre oj Japall. 
T H E JOURNAL OF INVESTIGATIVE DERMATOLOGY 
REFERENCES 
Amagai M: Adhesion molec ules. I. Keratinocyrc- kc l'atinocytc interactions. cadheriru 
and pemphigus. ] 1,,"eSI De,."lntol 1 04: '146-152, 1995 
Amagai M: Pemphigus: ;lUtoil11l11uni ty to epidermal cell adhesion molecules . Ad" 
Oel"l"olol 11 :319-352, 1996 
Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T: Antigen-specific 
iml11l1lloadsorption of pathogenic autoa ntibod ies in pemphigus foliaceus. J [rlVesl 
Oer",nloll 04:895-901, 1995a 
Amagai M, Hashimoto T, Shimizu N, N ishikawH T: Absorption of pathogenic 
autoantibod ies by the cxtrace llular domai n of pcmphigus vulg:uis antigen (Dsg3) 
produced by bacu lovirus.] CIi" J,, "est 94:59-67, 1994 
Amagai M, Ishii K, Hashimoto T , Gamou S, Shimizu N. Nishikawa T: Conformational 
cpitopcs of pemphigus antigc ns (Dsg1 and D sg3) arc calcium dependent and 
glycosylatiol1 independent.] 1,,"csl De""lIIlo /1 05:243- 247, 1995b 
Amagai M, Karpati S, I'russick R, Klaus- Kovtun V, Stan ley JR: Autoantibodies against 
thc. amino-termillul cadherin-Ukc binding domain of pcmphigus vulgaris antigen 
are pathogenic. ] CIi" lI111cs I 90:919-926, '1992 
Amagai M, Klaus-Kovtlln V, Stanley JR: Autoantibodies against a novel epithelial 
cadhcrin in pcmphigus vu lgaris. a disease of cell ad hesion. Cell 67:869-877, 
1991 
Amagai M, Koch pJ , Nishikawa T, Stanley JR: Pemphigus vulgaris antigen (desmo-
glein 3) is localized in the lower ep idermis , the site of blister formation in 
patients.] 1",'esl D',.,,10101106:351-355, 1996 
Eyre R W. Stan ley JR.: Idcntification of pemphigus vul garis antigcn extracted from. 
1101'111;11 human epidermis and comparison with pemphigus foliaceus antigen. 
] CIi" 1I111csl 81 :807-812, 1988 
Koza k M: An ana lysis ofS'-cod ing sequences fro III 699 vertebrate messenger RNAs. 
N "e/de Acids Res 15:8 '125-8148, 1987 
Neurath H: Proteolytic processing and physiological regulation. Tre"ds Bioehelll S<i 
14:268-27 1, 1989 
Ozawa M. Kcm.1cr R: Correct proteo lytic cleavage is required for the cell adhesive: 
function of uvomorulin.] Cell Bioi 11 'I :1645-1650, 1990 
H...apoport TA: Transport of proteins across the endoplasmic reticulum membrane. 
Scie"ce 258 :931-936, 1992 
Stan ley JI<.: Cell adhesion molecules as targets of autoantibodies in pemphigus and 
pcmph_igoid . bullous diseases due to derective epidermal cell adhesion. Adl' 
111111111110 1 53:291-325 , 1993 
Stan ley JR. Yaar M, Hawley Np, Katz SI: Pemphigus antibodies identify a cell surface 
glycoprotein synthesized by human and mouse keratinocytes. J Cli" [li ven 
70:281-288, 1982 
von Hcijne G: Protein targeting signal s. C",,. Opi" Cell Bioi 2:604-608, 1990 
